$0.58
8.73% yesterday
Nasdaq, Jul 29, 10:14 pm CET
ISIN
US15673T1007
Symbol
IPSC

Century Therapeutics Inc Stock price

$0.58
+0.03 4.55% 1M
-0.24 29.13% 6M
-0.43 42.17% YTD
-1.69 74.27% 1Y
-9.99 94.47% 3Y
-22.25 97.44% 5Y
-22.25 97.44% 10Y
-22.25 97.44% 20Y
Nasdaq, Closing price Tue, Jul 29 2025
-0.06 8.73%
ISIN
US15673T1007
Symbol
IPSC
Industry

Key metrics

Basic
Market capitalization
$55.1m
Enterprise Value
$-110.0m
Net debt
positive
Cash
$165.1m
Shares outstanding
86.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.5
EV/Sales
negative | negative
EV/FCF
1.0
P/B
0.2
Financial Health
Equity Ratio
45.7%
Return on Equity
-78.4%
ROCE
-10.9%
ROIC
-24.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$114.9m | $111.4m
EBITDA
$-19.6m | $-143.9m
EBIT
$-32.9m | $-27.9m
Net Income
$-21.7m | $-23.9m
Free Cash Flow
$-115.7m
Growth (TTM | estimate)
Revenue
8,286.9% | 1,589.8%
EBITDA
85.2% | -19.4%
EBIT
77.4% | 79.1%
Net Income
83.7% | 81.1%
Free Cash Flow
-17.5%
Margin (TTM | estimate)
Gross
-
EBITDA
-17.1% | -129.3%
EBIT
-28.6%
Net
-18.9% | -21.4%
Free Cash Flow
-100.7%
More
EPS
$-0.3
FCF per Share
$-1.3
Short interest
2.4%
Employees
159
Rev per Employee
$40.0k
Show more

Is Century Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Century Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Century Therapeutics Inc forecast:

10x Buy
83%
2x Hold
17%

Analyst Opinions

12 Analysts have issued a Century Therapeutics Inc forecast:

Buy
83%
Hold
17%

Financial data from Century Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
115 115
8,287% 8,287%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 33 33
5% 5%
29%
- Research and Development Expense 110 110
21% 21%
96%
-20 -20
85% 85%
-17%
- Depreciation and Amortization 13 13
0% 0%
12%
EBIT (Operating Income) EBIT -33 -33
77% 77%
-29%
Net Profit -22 -22
84% 84%
-19%

In millions USD.

Don't miss a Thing! We will send you all news about Century Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Century Therapeutics Inc Stock News

Neutral
GlobeNewsWire
2 months ago
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced two presentations at the upcoming European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, which is being held from June 1...
Neutral
GlobeNewsWire
3 months ago
PHILADELPHIA, May 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today reported financial results and business highlights for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
3 months ago
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced two presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, which is being held from May 13-...
More Century Therapeutics Inc News

Company Profile

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It engages in harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Head office United States
CEO Brent Pfeiffenberger
Employees 159
Founded 2018
Website www.centurytx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today